Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor–Treated Patients: CCTG MA.27,Journal of the National Cancer Institute

当前位置： X-MOL 学术 › J. Natl. Cancer Inst. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor–Treated Patients: CCTG MA.27
Journal of the National Cancer Institute ( IF 9.9 ) Pub Date : 2018-03-15 , DOI: 10.1093/jnci/djy017
Kathrin Strasser-Weippl ₁ , Michaela J Higgins ₂ , Judith-Anne W Chapman ₃ , James N Ingle ₄ , George W Sledge ₅ , George T Budd ₆ , Matthew J Ellis ₇ , Kathleen I Pritchard ₈ , Mark J Clemons ₉ , Tanja Badovinac-Crnjevic ₁₀ , Lei Han ₁ , Karen A Gelmon ₁₁ , Manuela Rabaglio ₁₂ , Catherine Elliott ₁ , Lois E Shepherd ₁ , Paul E Goss ₁₃

Affiliation

Center for Oncology, Hematology and Palliative Care, Wilhelminen Hospital, Vienna, Austria
Mater Misericordiae University Hospital, Dublin, Ireland
Canadian Cancer Trials Group, Queen’s University, Kingston, ON, Canada
Division of Medical Oncology, Mayo Clinic, Rochester, MN
Stanford University Medical Center, Stanford, CA
Taussig Cancer Center, Cleveland Clinic, Cleveland, OH
Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX
Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada
Division of Medical Oncology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada
Hoffman-La Roche, Basel, Switzerland
British Columbia Cancer Agency, Vancouver, BC, Canada
International Breast Cancer Study Group Coordinating Center, Inselspital, Berne, Switzerland
Massachusetts General Hospital, Harvard Medical School, Boston, MA